{"id":"https://openalex.org/W2936036393","doi":null,"title":"Ribociclib Offers Substantial PFS Improvement in Advanced, Premenopausal Breast Cancer","display_name":"Ribociclib Offers Substantial PFS Improvement in Advanced, Premenopausal Breast Cancer","alternate_titles":[],"publication_year":2017,"publication_date":"2017-12-06","ids":{"openalex":"https://openalex.org/W2936036393","mag":"2936036393"},"language":"en","primary_location":{"id":"mag:2936036393","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/article/ribociclib-offers-substantial-pfs-improvement-advanced-premenopausal-breast-cancer","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2936036393"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012027631","display_name":"Dave Levitan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Dave Levitan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5012027631"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ribociclib","display_name":"ribociclib","score":1.0},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9409999847412109},{"id":"https://openalex.org/keywords/premenopausal-breast-cancer","display_name":"premenopausal breast cancer","score":0.8759999871253967},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8809999823570251},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.9380000233650208},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.9909999966621399},{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":0.9660000205039978},{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.8830000162124634}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6377251148223877},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6187142729759216},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48582765460014343},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.4399987757205963},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4189608693122864},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4161509573459625}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2936036393","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/article/ribociclib-offers-substantial-pfs-improvement-advanced-premenopausal-breast-cancer","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2943730803","https://openalex.org/W4211209146","https://openalex.org/W2803848650","https://openalex.org/W2791025732","https://openalex.org/W2945979059","https://openalex.org/W2885826477","https://openalex.org/W4360614769","https://openalex.org/W2801742741","https://openalex.org/W2948069739","https://openalex.org/W2801701165"],"abstract_inverted_index":{"The":[0],"addition":[1],"of":[2],"the":[3],"CDK4/6":[4],"inhibitor":[5,16],"ribociclib":[6],"to":[7],"endocrine":[8],"therapy":[9],"with":[10,26],"either":[11],"tamoxifen":[12],"or":[13],"an":[14],"aromatase":[15],"significantly":[17],"improved":[18],"progression-free":[19],"survival":[20],"among":[21],"premenopausal":[22],"and":[23],"perimenopausal":[24],"women":[25],"breast":[27],"cancer.":[28]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2936036393","counts_by_year":[],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2019-04-25T00:00:00"}
